Categories: News

Boosh Closes Initial Public Offering

Vancouver, British Columbia–(Newsfile Corp. – May 26, 2021) – Boosh Plant-Based Brands Inc. (CSE: VEGI) (the “Company“) is pleased to announce that it has completed its initial public offering of 5,750,000 units (each a “Unit“) issued at a price of $0.50 per Unit, which included the exercise in full of an over-allotment option. This generated aggregate gross proceeds of $2,875,000 pursuant to a prospectus dated May 7, 2021 (the “Prospectus“).

The Company now has 15,575,500 issued and outstanding common shares, of which 4,416,439 common shares are held in escrow.

Each Unit comprised one common share of the Company (each a “Share“) and one common share purchase warrant (each a “Warrant“). Each Warrant entitles the holder to acquire one additional Share at an exercise price of $1.00 per Share until May 26, 2022. The Warrants were issued pursuant to a warrant indenture dated May 26, 2021 between the Company and its warrant agent , Odyssey Trust Company. A copy of which is available under the Company’s profile on SEDAR at www.sedar.com.

A commission equal to 10% of the gross proceeds of the offering was paid to the Company’s agent, Haywood Securities Inc. (the “Agent“), through the issuance of an aggregate of 575,000 Units, as well as a corporate finance fee of $40,000, plus applicable taxes, of which $20,000 was paid in cash and the remainder through the issuance of 40,000 Units. In addition, the Agent and its selling group members received 575,000 non-transferable agent’s options to acquire up to 575,000 Shares at a price of $0.50 per Share until May 26, 2022.

The Company also granted an aggregate of 100,000 incentive stock options to consultants as outlined in the Prospectus. Each option is exercisable at a price of $0.50 per share for a period of two years, vesting immediately.

The Company will use the net proceeds from the offering in furtherance of its short term business objectives as outlined in the Prospectus. A copy of the Prospectus is available under the Company’s profile on SEDAR at www.sedar.com.

The Company’s common shares are listed for trading on the CSE under the trading symbol “VEGI” on May 26, 2021 and are expected to commence trading on May 27, 2021.

The securities of the Company have not been and will not be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”) or any state securities laws. Accordingly, the securities of the Company may not be offered or sold within the United States unless registered under the U.S. Securities Act and applicable state securities laws or pursuant to an exemption from the registration requirements of the U.S. Securities Act and applicable state securities laws. This news release does not constitute an offer to sell or a solicitation of any offer to buy any securities of the Company in any jurisdiction in which such offer, solicitation or sale would be unlawful.

On behalf of the Board of Directors

James Pakulis
Chief Executive Officer

Telephone: (833) 882-6674

The information in this news release includes certain information and statements about management’s view of future events, expectations, plans and prospects that constitute forward looking statements. These statements are based upon assumptions that are subject to significant risks and uncertainties. Because of these risks and uncertainties and as a result of a variety of factors, the actual results, expectations, achievements or performance may differ materially from those anticipated and indicated by these forward looking statements. Forward-looking statements in this news release include, but are not limited to, the Company’s proposed use of the proceeds of its initial public offering. Any number of factors could cause actual results to differ materially from these forward-looking statements as well as future results. Although the Company believes that the expectations reflected in forward looking statements are reasonable, it can give no assurances that the expectations of any forward looking statements will prove to be correct. Except as required by law, the Company disclaims any intention and assumes no obligation to update or revise any forward looking statements to reflect actual results, whether as a result of new information, future events, changes in assumptions, changes in factors affecting such forward looking statements or otherwise.

Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/85365

Staff

Recent Posts

Best Testosterone Supplement For Men Over 40 and 50: Testo Prime for Muscle Growth & Libido 2025

If you are male and in your 40's and 50's and feel your testosterone levels…

5 hours ago

The Anxiety Clinic Launches Innovative Approach to Transform Anxiety into Positive Energy

Transforming Anxiety into Positive Energy: A New Approach by The Anxiety ClinicBondi Junction, New South…

9 hours ago

Solace Psychology Announces Expanded Holiday Stress Management and Mental Health Support Services

Embracing Mental Well-Being During the Festive SeasonCarlton North, Australia--(Newsfile Corp. - December 24, 2024) -…

11 hours ago

Strong Natural Diet Pill Over the Counter for 2025 – PhenQ OTC Weight Loss Supplement

If you are researching the strongest over the counter weight loss supplements in 2025 -…

11 hours ago

Fortitude Wellbeing Enhances Mental Health Services with Comprehensive ADHD Assessments

Fortitude Wellbeing Expands Offerings with ADHD AssessmentsSouth Yarra, Australia--(Newsfile Corp. - December 24, 2024) -…

13 hours ago

MedMira receives Health Canada approval for its Multiplo(R) Rapid (TP/HIV) Test for Syphilis and HIV

HALIFAX, NS / ACCESSWIRE / December 24, 2024 / MedMira Inc. (MedMira) (TSXV:MIR) announced today…

14 hours ago